@misc{indiciae735478eeb14a,
  title = {The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2},
  author = {Suryawanshi, R. K. and Jaishankar, P. and Correy, G. J. and Rachman, M. M. and O'Leary, P. C. and Taha, T. Y. and Zapatero-Belinchon, F. J. and McCavitt-Malvido, M. and Doruk, Y. U. and Stevens, M. G. V. and Diolati, M. E. and Jogalekar, M. P. and Richards, A. L. and Montano, M. and Rosecrans, J. and Matthay, M. and Togo, T. and Gonciarz, R. L. and Gopalkrishnan, S. and Neitz, R. J. and Krogan, N. J. and Swaney, D. L. and Shoichet, B. K. and Ott, M. and Renslo, A. R. and Ashworth, A. and Fraser, J. S.},
  year = {2024},
  doi = {10.1101/2024.08.08.606661},
  url = {https://www.biorxiv.org/content/10.1101/2024.08.08.606661v1},
  note = {Source identifier: 10.1101/2024.08.08.606661}
}